Across TCGA pan-cancer cohorts, LDHAL6FP RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LDHAL6FP’s most consistent transcriptional readouts.

The strongest signal is observed in rectum adenocarcinoma (READ), where LDHAL6FP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LDHAL6FP is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

READ, HNSC, and THCA are the cancer types where LDHAL6FP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LDHAL6FP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
READ	All	All	+0.248	.017	4	view →
HNSC	All	IV	+0.060	<.001	3	view →
THCA	Female	III,IV	−0.103	.026	2	view →
LUAD	All	All	+0.094	.028	1	view →
LUSC	All	All	+0.081	.027	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: LDHAL6FP RNA expression & survival · all LDHAL6FP data types